207 related articles for article (PubMed ID: 32702400)
1. Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma.
Said S; Kurtin PJ; Nasr SH; Graham RP; Dasari S; Vrana JA; Yasir S; Torbenson MS; Zhang L; Mounajjed T; Eric Chen ZM; Lee HE; Wu TT
Hum Pathol; 2020 Sep; 103():120-126. PubMed ID: 32702400
[TBL] [Abstract][Full Text] [Related]
2. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas.
Uhlig R; Contreras H; Weidemann S; Gorbokon N; Menz A; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Sauter G; Wilczak W; Izbicki J; Perez D; Schrader J; Steurer S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R; Minner S; Jacobsen F; Clauditz TS
Am J Surg Pathol; 2022 Jan; 46(1):97-104. PubMed ID: 34889867
[TBL] [Abstract][Full Text] [Related]
3. Novel Insights Into Immunohistochemical Analysis For Acinar Cell Neoplasm of The Pancreas: Carboxypeptidase A2, Carboxypeptidase A1, and Glycoprotein 2.
Ishimoto-Namiki U; Ino Y; Esaki M; Shimada K; Saruta M; Hiraoka N
Am J Surg Pathol; 2023 May; 47(5):525-534. PubMed ID: 36815573
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic Cast Nephropathy Associated With Pancreatic Mixed Acinar-Neuroendocrine Carcinoma: A Case Report.
Nasr SH; Wehbe E; Said SM; Dasari S; Quoc T; Kurtin PJ
Am J Kidney Dis; 2019 Oct; 74(4):558-562. PubMed ID: 30952487
[TBL] [Abstract][Full Text] [Related]
5. Bcl-10, trypsin and synaptophysin helps recognize acinar cell and mixed acinar neuroendocrine cell carcinoma of the pancreas on both preoperative cytological samples and needle biopsy specimens.
Manfrin E; Parisi A; Stefanizzi L; D'Onofrio M; Bernardoni L; Crino SF; Pelosi G; Pancione M; Giordano G; Sina S; Remo A
Pathol Res Pract; 2021 Oct; 226():153593. PubMed ID: 34481211
[TBL] [Abstract][Full Text] [Related]
6. BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Pathol Int; 2013 Mar; 63(3):176-82. PubMed ID: 23530562
[TBL] [Abstract][Full Text] [Related]
7. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.
Li Q; Wang H; Zogopoulos G; Shao Q; Dong K; Lv F; Nwilati K; Gui XY; Cuggia A; Liu JL; Gao ZH
Oncotarget; 2016 Nov; 7(47):77838-77853. PubMed ID: 27788482
[TBL] [Abstract][Full Text] [Related]
8. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.
La Rosa S; Franzi F; Marchet S; Finzi G; Clerici M; Vigetti D; Chiaravalli AM; Sessa F; Capella C
Virchows Arch; 2009 Feb; 454(2):133-42. PubMed ID: 19066953
[TBL] [Abstract][Full Text] [Related]
9. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
[TBL] [Abstract][Full Text] [Related]
10. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms: A Potential Diagnostic Pitfall.
Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
12. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic acinar cell carcinoma is associated with
Kryklyva V; Haj Mohammad N; Morsink FHM; Ligtenberg MJL; Offerhaus GJA; Nagtegaal ID; de Leng WWJ; Brosens LAA
Cancer Biol Ther; 2019; 20(7):949-955. PubMed ID: 31002019
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Mixed Acinar-neuroendocrine-ductal Carcinoma: A Case Report and Literature Review.
Sakaguchi R; Yamada R; Nose K; Tanaka T; Murashima Y; Tsuboi J; Nakagawa H
Intern Med; 2023 Nov; 62(22):3347-3353. PubMed ID: 37032087
[TBL] [Abstract][Full Text] [Related]
15. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
16. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
Sangoi AR; Ohgami RS; Pai RK; Beck AH; McKenney JK; Pai RK
Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic characterisitics of pancreatic acinar cell carcinomas].
Ding XH; Wang ZB; Qiu XM
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):274-278. PubMed ID: 29690667
[No Abstract] [Full Text] [Related]
18. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T
Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220
[TBL] [Abstract][Full Text] [Related]
19. The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma.
Yasumoto M; Hamabashiri M; Akiba J; Ogasawara S; Naito Y; Taira T; Nakayama M; Daicho A; Yamasaki F; Shimamatsu K; Ishida Y; Kaji R; Okabe Y; Nakashima O; Ohshima K; Nakashima M; Sata M; Yano H
J Clin Pathol; 2012 Apr; 65(4):327-32. PubMed ID: 22228907
[TBL] [Abstract][Full Text] [Related]
20. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.
Tanigawa M; Nakayama M; Taira T; Hattori S; Mihara Y; Kondo R; Kusano H; Nakamura K; Abe Y; Ishida Y; Okabe Y; Hisaka T; Okuda K; Fujino K; Ito T; Kawahara A; Naito Y; Yamaguchi R; Akiba J; Akagi Y; Yano H
Med Mol Morphol; 2018 Mar; 51(1):32-40. PubMed ID: 28849340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
